Anthracyclines are an effective chemotherapy agent. However, very few cases of idarubicin-induced cardiomyopathy exist. Herein, we describe a case of first-dose idarubicin-related acute heart failure in a woman with a history of myelodysplastic syndrome converted to acute myeloid leukaemia.
|Original language||English (US)|
|Journal||BMJ Case Reports|
|State||Published - May 16 2019|
- cardiovascular system
- haematology (incl blood transfusion)
- heart failure
ASJC Scopus subject areas